Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EDNRB antisense RNA 1 (EDNRB-AS1) is a long non-coding RNA (lncRNA), classified as an antisense transcript, located on human chromosome 13. It is transcribed in the opposite direction to the EDNRB (endothelin receptor type B) gene, but does not code for a protein. Several diseases have shown genetic association with EDNRB-AS1, including Waardenburg syndrome type 4A and Abcd syndrome; however, the direct pathogenic role or specific biological functions of EDNRB-AS1 remain unclear. No drugs are known to target this RNA, and it is not currently considered a standard therapeutic target. EDNRB-AS1 is part of the emerging class of lncRNAs implicated in regulation of neighboring or overlapping protein-coding genes, but further research is needed to determine its full biological roles.
Not applicable (no known drugs or therapeutic modulation as of yet)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EDNRB antisense RNA 1 (EDNRB-AS1).